[Ce direct est désormais terminé]
He wants to avoid shortages and regain pharmaceutical sovereignty. From the Ardèche, Emmanuel Macron announced on Tuesday, June 13, that the production of around fifty drugs would be “relocated” in France, including 25 “in the next weeks”. He notably cited the active ingredients of morphine, amoxicillin and six anti-cancer drugs. To do this, the President has put on the table a total investment of more than 160 million euros.
He wants to “go faster” on biomedicines. Emmanuel Macron has called upon to simplify the “clinical tests” and to solidify “the innovative purchase of technologies” with the objective “20 biomedicines in France”, those drugs that come from living organisms or their cells. “We have to go much faster”he pleaded.
Compile a list of essential drugs. “A single list of drugs to treat our fellow citizens” will be detailed by the Minister of Health this afternoon, promised Emmanuel Macron. She will “scalable” And “counts 450 drugs” for the moment.
A white drug plan as a last resort. For the most critical cases of shortages, “a white drug plan will be developed, as we know how to do for our structures”concluded the president, without giving more details on this device already announced by the ministry.